182 related articles for article (PubMed ID: 8824283)
41. Cathepsin B activity regulation. Heparin-like glycosaminogylcans protect human cathepsin B from alkaline pH-induced inactivation.
Almeida PC; Nantes IL; Chagas JR; Rizzi CC; Faljoni-Alario A; Carmona E; Juliano L; Nader HB; Tersariol IL
J Biol Chem; 2001 Jan; 276(2):944-51. PubMed ID: 11016923
[TBL] [Abstract][Full Text] [Related]
42. Interaction of high molecular weight chondroitin sulfate from human aorta with plasma low density lipoproteins.
Alves CS; Mourão PA
Atherosclerosis; 1988 Oct; 73(2-3):113-24. PubMed ID: 3142491
[TBL] [Abstract][Full Text] [Related]
43. Purification and characterization of protease-resistant secretory granule proteoglycans containing chondroitin sulfate di-B and heparin-like glycosaminoglycans from rat basophilic leukemia cells.
Seldin DC; Austen KF; Stevens RL
J Biol Chem; 1985 Sep; 260(20):11131-9. PubMed ID: 2411730
[TBL] [Abstract][Full Text] [Related]
44. Glycosaminoglycans and proteoglycans synthesized by rat limb buds during prechondrogenic and chondrogenic stages.
Matsui F; Oohira A; Shoji R; Nogami H
Differentiation; 1986; 31(1):29-34. PubMed ID: 3089858
[TBL] [Abstract][Full Text] [Related]
45. Release of heparan sulfate glycosaminoglycans from proteoglycans in Chinese hamster ovary cells does not require proteolysis of the core protein.
Bame KJ
J Biol Chem; 1993 Sep; 268(27):19956-64. PubMed ID: 8376358
[TBL] [Abstract][Full Text] [Related]
46. Complexes of heparin proteoglycans, chondroitin sulfate E proteoglycans, and [3H]diisopropyl fluorophosphate-binding proteins are exocytosed from activated mouse bone marrow-derived mast cells.
Serafin WE; Katz HR; Austen KF; Stevens RL
J Biol Chem; 1986 Nov; 261(32):15017-21. PubMed ID: 3095324
[TBL] [Abstract][Full Text] [Related]
47. Abeta(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease.
Bame KJ; Danda J; Hassall A; Tumova S
J Biol Chem; 1997 Jul; 272(27):17005-11. PubMed ID: 9202014
[TBL] [Abstract][Full Text] [Related]
48. Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100.
Flood C; Gustafsson M; Pitas RE; Arnaboldi L; Walzem RL; Borén J
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):564-70. PubMed ID: 14726411
[TBL] [Abstract][Full Text] [Related]
49. Metabolism of sulfated glycosaminoglycans in cultured endothelial cells and smooth muscle cells from bovine aorta.
Gamse G; Fromme HG; Kresse H
Biochim Biophys Acta; 1978 Dec; 544(3):514-28. PubMed ID: 728470
[TBL] [Abstract][Full Text] [Related]
50. Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation.
Hanasaki K; Yamada K; Yamamoto S; Ishimoto Y; Saiga A; Ono T; Ikeda M; Notoya M; Kamitani S; Arita H
J Biol Chem; 2002 Aug; 277(32):29116-24. PubMed ID: 12021277
[TBL] [Abstract][Full Text] [Related]
51. Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains.
Graham LD; Whitelock JM; Underwood PA
Biochem Biophys Res Commun; 1999 Mar; 256(3):542-8. PubMed ID: 10080934
[TBL] [Abstract][Full Text] [Related]
52. Heparan sulfate proteoglycan synthesis and metabolism by mouse uterine epithelial cells cultured in vitro.
Tang JP; Julian J; Glasser SR; Carson DD
J Biol Chem; 1987 Sep; 262(26):12832-42. PubMed ID: 2957379
[TBL] [Abstract][Full Text] [Related]
53. Identification and characterization of ligands for L-selectin in the kidney. II. Expression of chondroitin sulfate and heparan sulfate proteoglycans reactive with L-selectin.
Li YF; Kawashima H; Watanabe N; Miyasaka M
FEBS Lett; 1999 Feb; 444(2-3):201-5. PubMed ID: 10050759
[TBL] [Abstract][Full Text] [Related]
54. Characterization of a heparan sulfate proteoglycan that copurifies with the neural cell adhesion molecule.
Cole GJ; Burg M
Exp Cell Res; 1989 May; 182(1):44-60. PubMed ID: 2523815
[TBL] [Abstract][Full Text] [Related]
55. Secretory phospholipase A2 group V: lesion distribution, activation by arterial proteoglycans, and induction in aorta by a Western diet.
Rosengren B; Peilot H; Umaerus M; Jönsson-Rylander AC; Mattsson-Hultén L; Hallberg C; Cronet P; Rodriguez-Lee M; Hurt-Camejo E
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1579-85. PubMed ID: 16601231
[TBL] [Abstract][Full Text] [Related]
56. Anchorage of collagen-tailed acetylcholinesterase to the extracellular matrix is mediated by heparan sulfate proteoglycans.
Brandan E; Maldonado M; Garrido J; Inestrosa NC
J Cell Biol; 1985 Sep; 101(3):985-92. PubMed ID: 3161900
[TBL] [Abstract][Full Text] [Related]
57. Low density lipoprotein binding affinity of arterial wall isomeric chondroitin sulfate proteoglycans.
Srinivasan SR; Vijayagopal P; Eberle K; Dalferes ER; Radhakrishnamurthy B; Berenson GS
Atherosclerosis; 1988 Jul; 72(1):1-9. PubMed ID: 3214455
[TBL] [Abstract][Full Text] [Related]
58. Isolation and characterization of the heparan sulfate proteoglycans of brain. Use of affinity chromatography on lipoprotein lipase-agarose.
Klinger MM; Margolis RU; Margolis RK
J Biol Chem; 1985 Apr; 260(7):4082-90. PubMed ID: 3156851
[TBL] [Abstract][Full Text] [Related]
59. Varied low density lipoprotein binding property of proteoglycans synthesized by vascular smooth muscle cells cultured on extracellular matrix.
Vijayagopal P; Menon PV
Atherosclerosis; 2005 Jan; 178(1):75-82. PubMed ID: 15585203
[TBL] [Abstract][Full Text] [Related]
60. Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells.
Hurt-Camejo E; Camejo G; Rosengren B; López F; Ahlström C; Fager G; Bondjers G
Arterioscler Thromb; 1992 May; 12(5):569-83. PubMed ID: 1576119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
